Novel gene-correction-based therapeutic modalities for monogenic liver disorders

HIGHLIGHTS

  • who: Mahsa Ghasemzad and collaborators from the Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell and Technology, Academic Center for Education, Culture and Research, Tehran, Iran, University of Science and Culture, Tehran, Iran have published the research: Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders, in the Journal: Bioengineering 2022, 9, x FOR PEER REVIEW of /2022/
  • what: The results of this study demonstrated that the AAT-knockout and PiZZ ferrets model the progressive pulmonary and liver disease and may serve as a platform for gene therapy .
  •  

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?